Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06528418
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-18
Brief Title:
Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Exploration and Study on the Identification of Various Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this observational study is to develop an advanced expiratory algorithm model utilizing exhaled breath volatile organic compound VOC marker molecules This model aims to accurately diagnose mutiple pulmonary diseases The primary objectives it strives to accomplish are
1 To assess the diagnostic accuracy of an exhaled breath VOC-assisted diagnostic artificial intelligence AI model in diagnose several common pulmonary diseases
2 To assess the diagnostic accuracy of an exhaled breath VOC-assisted diagnostic artificial intelligence AI model in diagnose more pulmonary diseases
1 To assess the diagnostic accuracy of an exhaled breath VOC-assisted diagnostic artificial intelligence AI model in diagnose several common pulmonary diseases
2 To assess the diagnostic accuracy of an exhaled breath VOC-assisted diagnostic artificial intelligence AI model in diagnose more pulmonary diseases
Detailed Description:
This is a prospective cross-sectional observational cohort study aimed at recruiting 10000 participants with multiple pulmonary disease including lung cancer lung infection chronic obstructive pulmonary disease COPD bronchitis pulmonary fibrosis pulmonary embolism pulmonary arterial hypertension tuberculosis lung abscess emphysema radioactive lung injury cystic fibrosis of the lung Bronchial Asthma Bronchiectasis interstitial lung disease ILD preserved ratio impaired spirometry PRISm etc Exhaled breath samples from these participants will be collected and analyzed using Gas chromatography-mass spectrometryGC-MS and micro Gas Chromatography-photoionisation detector μGC-PID system Upon obtaining the μGC-PID results a comprehensive evaluation of the diagnostic capabilities of exhaled breath samples in differentiating various pulmonary diseases will be performed leveraging clinical diagnostic results CT examination data and clinical data
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None